Tandem Diabetes Care Inc

TD5A

Company Profile

  • Business description

    Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

  • Contact

    12400 High Bluff Drive
    San DiegoCA92130
    USA

    T: +1 858 366-6900

    E: [email protected]

    https://www.tandemdiabetes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    2,650

Stocks News & Analysis

stocks

Solving the Australian equities conundrum

Where to look in a heavily concentrated index.
stocks

Cutting our fair value on ASX share after poor guidance

Our view after the shares stand after a 20% drop.
stocks

2 companies poised to capitalize on the rise of GLP-1 drugs

Why Pfizer and Roche look like top choices for investors in the war to tip the scales.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,868.2033.10-0.37%
CAC 408,016.0436.47-0.45%
DAX 4024,077.1185.54-0.35%
Dow JONES (US)47,685.19124.900.26%
FTSE 1009,662.9320.920.22%
HKSE25,540.78106.550.42%
NASDAQ23,465.63110.86-0.47%
Nikkei 22550,602.8052.30-0.10%
NZX 50 Index13,371.0683.72-0.62%
S&P 5006,833.147.37-0.11%
S&P/ASX 2008,579.4031.70-0.37%
SSE Composite Index3,900.509.03-0.23%

Market Movers